Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hermans

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Oncoimmunology|June 5, 2013
Exploiting invariant NKT cells to promote T-cell responses to cancer vaccinesMartin K Hunn, Ian F Hermans
Drugs|December 23, 2016
Engaging Natural Killer T Cells as 'Universal Helpers' for VaccinationMary Speir, Ian F Hermans, Robert Weinkove
Critical Reviews in Immunology|July 30, 2010
Tumor antigen presentation by dendritic cellsTroels R Petersen, Nina Dickgreber, Ian F Hermans
Critical Reviews in Oncogenesis|February 29, 2024
Recruiting Natural Killer T Cells to Improve Vaccination: Lessons from Preclinical and Clinical StudiesOlivia K Burn, Nathaniel Dasyam, Ian F Hermans
Cancers|December 23, 2020
Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor AgonistsOlivia K Burn, Kef K Prasit, Ian F Hermans
Molecular Immunology|December 19, 2020
Using agonists for iNKT cells in cancer therapyGavin F Painter, Olivia K Burn, Ian F Hermans
Magnetic Resonance in Chemistry : MRC|August 4, 2016
Determining mean fractional anisotropy using DDCOSY: preliminary results in biological tissuesFangrong Zong, Lindsay R Ancelet, Ian F Hermans, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 1997
Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challengeI F Hermans, A Daish, P Moroni-Rawson, et al.
Scandinavian Journal of Immunology|December 9, 2004
B-Lymphocytes activated by CD40 ligand induce an antigen-specific anti-tumour immune response by direct and indirect activation of CD8(+) T-cellsD S Ritchie, J Yang, I F Hermans, et al.
Oncoimmunology|July 3, 2015
An adjuvanted whole cell vaccine as post-remission immunotherapy for acute leukemiaRobert Weinkove, Lindsay R Ancelet, John D Gibbins, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Oncoimmunology|June 5, 2013
Exploiting invariant NKT cells to promote T-cell responses to cancer vaccinesMartin K Hunn, Ian F Hermans
Drugs|December 23, 2016
Engaging Natural Killer T Cells as 'Universal Helpers' for VaccinationMary Speir, Ian F Hermans, Robert Weinkove
Critical Reviews in Immunology|July 30, 2010
Tumor antigen presentation by dendritic cellsTroels R Petersen, Nina Dickgreber, Ian F Hermans
Critical Reviews in Oncogenesis|February 29, 2024
Recruiting Natural Killer T Cells to Improve Vaccination: Lessons from Preclinical and Clinical StudiesOlivia K Burn, Nathaniel Dasyam, Ian F Hermans
Cancers|December 23, 2020
Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor AgonistsOlivia K Burn, Kef K Prasit, Ian F Hermans
Molecular Immunology|December 19, 2020
Using agonists for iNKT cells in cancer therapyGavin F Painter, Olivia K Burn, Ian F Hermans
Magnetic Resonance in Chemistry : MRC|August 4, 2016
Determining mean fractional anisotropy using DDCOSY: preliminary results in biological tissuesFangrong Zong, Lindsay R Ancelet, Ian F Hermans, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 1997
Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challengeI F Hermans, A Daish, P Moroni-Rawson, et al.
Scandinavian Journal of Immunology|December 9, 2004
B-Lymphocytes activated by CD40 ligand induce an antigen-specific anti-tumour immune response by direct and indirect activation of CD8(+) T-cellsD S Ritchie, J Yang, I F Hermans, et al.
Oncoimmunology|July 3, 2015
An adjuvanted whole cell vaccine as post-remission immunotherapy for acute leukemiaRobert Weinkove, Lindsay R Ancelet, John D Gibbins, et al.
Pageof 13